clinical approaches have completely altered the management as well as the prevention of heart diseases. The magnitude of these exciting events is readily grasped by those of us who were witnesses to this evolution. The selection of "breakthrough" advances is highly individual and obviously cannot be complete given limitations of space. Furthermore, it seems worthwhile to report some "misses" in addition to the "hits" to remind us that advances enthusiastically accepted today may be abandoned tomorrow. This review represents a personal appraisal of progress.
State of the art circa 1935
Cardiology was beginning to emerge as a subspecialty of internal medicine. Evaluation of patients with cardiac disease was made on the basis of history, physical examination, and a small number of available laboratory tests. Electrocardiography in many institutions involved three Einthoven leads (presently leads I, LI, and ILL). In some, a fourth lead had been added, lead IV (apical chest lead connected with the right arm). Radiologic examination consisted predominantly of fluoroscopy and orthodiagrams of the heart (drawing on semiopaque paper the outline of the cardiac border in the anteroposterior position using the central fluoroscopic beam). Many outpatient clinics and physician offices had fluoroscopic facilities available for cardiologists' use. Clinical laboratory tests used by cardiologists in addition to routine blood and urine tests included erythrocyte sedimentation test and blood cultures.
Hospital inpatient populations, at that time differed in many respects from today's. Rheumatic fever and rheumatic heart disease at several stages, particularly advanced mitral stenosis, were prominent. Coronary Vol. 77, No. 5, May 1988 artery disease was represented mostly as classical "transmural" myocardial infarction with relatively few cases of lesser coronary syndromes. Patients were hospitalized infrequently for arrhythmias. Some diseases rarely encountered today were frequently seen in hospital wards, such as luetic aortic regurgitation, luetic aortic aneurysms, tuberculous pericarditis, and heart failure caused by benign or malignant hypertension.
Management of cardiac disease could best be described as supportive: regulation of activities, complete rest in some cases, diet, weight reduction, sedation. Oxygen was usually administered by means of oxygen tents. Few cardiac drugs were available: Digitalis, usually administered orally as powdered leaf, was used for slowing ventricular rate in atrial fibrillation and to a lesser extent for heart failure with sinus rhythm. Quinidine was used for restoration of sinus rhythm in atrial fibrillation and for prevention of atrial and ventricular arrhythmias. Theobromine was the only available oral diuretic and had questionable effectiveness; mercurial diuretics (mersalyl) were available, but their use was limited to intravenous administration. Antianginal drugs consisted of amyl nitrite (by inhalation) and sublingual nitroglycerin for relief of anginal attacks. Long-acting nitrates were available (erythritol tetranitrate, mannitol pentanitrate), but their effectiveness was questioned.
Other modes of therapy included interventions. Massive edema was treated by paracentesis of the pleural or abdominal cavities and with Southey tubes (inserted into patient's legs subcutaneously by trocars). First attempts to treat angina pectoris surgically had been made by implantation of the pectoral muscle into the pericardium; this was thought to collateralize with the coronary circulation. Another approach to relief of angina was dorsal sympathectomy. Thyroidectomies were performed in some cases of intractable angina and advanced cardiac failure based on the hypothesis that reduction of myocardial metabolic demands could alleviate coronary insufficiency as well as cardiac failure. Pericardial resection was performed for constrictive pericarditis.
SELZER
The period just before World War II can be characterized by progress in diagnostic approaches to heart disease and early development of clinical physiology but failure to develop effective therapy for most cardiac diseases. Detailed studies of the mechanism of cardiac arrhythmias and measurement of cardiac output in man by the acetylene methods are examples. The diagnostic criteria for several congenital cardiac lesions and pulmonary hypertension exemplified the considerable sophistication of the period.
Evolution of present-day cardiology
Clinical diagnosis Physical examination. Development of physical examination of the cardiac patient dates back to the last century. Major progress in recent years was related to the growth of clinical physiology whereby auscultatory findingsheart sounds and murmurscould be correlated with physiologic events occurring during the cardiac cycle. The diagnostic value of the abnormal splitting of the second sound, the ejection sound, systolic click, and gallop sounds, were defined. Murmurs were classified. The results was refinement in cardiac diagnosis abetted by the development of modern phonocardiography and its correlations with echocardiography. l Electrocardiography. Einthoven's string galvanometer represented the standard electrocardiograph until the mid-1930s, when portable electronically amplified electrocardiographic instruments became available. A decade later, direct-writing equipment replaced photographic recorders.
In the nonarrhythmic use of the electrocardiogram, the three original leads had been supplemented by lead IV,2 which was widely though not universally used previously. Based on Wilson's studies,3 six precordial leads were developed and officially recommended in 1938. 4 Wilson's concept of "unipolar" leads was later accepted as providing a zero-potential central terminal. Four years later, Goldberger5 popularized the "augmented" unipolar extremity leads (present leads aVR, aVL, aVF) and the modern, standard 12-lead electrocardiogram became almost universally accepted.
The concept of spacial orientation of electromotive forces generated by the heart had been developed earlier; however, its practical application originated in Wilson's laboratory as "vectorcardiography."6 The diagnostic use of vectorcardiography was popularized in the 1950s, when oscilloscopic recording of vector loops became practical. Advantages were considered to include use of "orthogonal" leads that could eliminate proximity distortion of precordial leads and provide a three-dimensional orientation, offering a better electrophysiologic foundation for the displayed electrical potential. Enthusiasts predicted that vector loops would totally replace 12-lead electrocardiography. However, these expectations have not been fulfilled. The diagnostic value of electrocardiographic contour abnormalities was (and still is) based on correlation with clinical and pathologic findings. The electrocardiogram's empirical value gained little from three-dimensional displays. Vectorcardiography was gradually abandoned as a diagnostic tool. Except for minor refinements, diagnostic application of 12-lead electrocardiography reflects little change in the criteria developed after its initial adoption three decades ago.
Progress in electrocardiography is mostly evident in the application of special techniques that enhance the diagnosis of ischemia and of arrhythmias. The relationship between myocardial ischemia and electrocardiographic ST segment shifts had been recognized in the early days of electrocardiography. It has now become obvious that the electrocardiogram can be used in the diagnosis of provoked myocardial ischemia. The two earliest methods of induction of ischemia consisted of exercise and inhalation of oxygen-poor gas mixture. The former was popularized with Master's two-step test.7 The latter, suggested by Levy et al.,8 was abandoned because of unacceptable risk. Master's test was used widely more than 30 years ago until results of research in exercise physiology, performed mostly in Sweden, suggested that a more gradual initiation of exercise was superior to rapid bursts of energy elicited by fast stair climbing. Thus the use of bicycle ergometer (in Europe) or treadmill (in this country) was introduced. The exercise protocol designed by Bruce was generally adopted.9 Today, the treadmill test, complemented by radionuclide perfusion techniques, is widely used to detect coronary artery disease.
Radiology. Radiographic display of the cardiac shadow by chest films with a 2 meter tube-to-target distance remains a fundamental diagnostic procedure, essentially unchanged for decades. Fluoroscopic examination has become simplified immensely and improved by the development of image intensification essential for interventional techniques. However, the major advances in radiology of the heart occurred with the development of contrast visualization of the cardiovascular system. In the mid-1930s, injection of iodine-containing contrast solutions into the venous system had been performed in Portugal and Cuba; first attempts to use intravenous contrast visualization in the diagnosis of congenital heart disease were successfully made by Robb and Steinberg.'0 Further advances 956 CIRCULATION included the development of selective angiocardiography performed in conjunction with cardiac catheterization. The most important application of angiography was the evolution of selective coronary arteriography by Sones,1" a technique that made present-day interventional management of coronary artery disease possible.
Echocardiography. Ultrasonic examination of the heart revolutionized cardiac diagnosis and represents the most important development in noninvasive cardiology. Yet, echocardiography had a very slow and inauspicious beginning. The use of ultrasound in the study of the heart had been suggested more than 40 years ago, and by 1955 Edler12 in Sweden had developed ultrasound as a means of examining the mitral valve and demonstrating pericardial effusion. However, not until the past two decades did a wide range of diagnostic applications become apparent. The development of two-dimensional, real-time echocardiographic display provided further impetus and made echocardiography an indispensible tool of the cardiologist. Further refinement has been made by the recent improvement in the application of the Doppler principle to ultrasonography.
Nuclear cardiology. The use of isotopes in cardiology dates back more than 60 years, when Blumgart and Weiss evaluated the speed of the circulation through its various segments. Initially used for investigative purposes only, radionuclide techniques became important diagnostic procedures with the development of a largecrystal scintillation camera. Some early techniques were abandoned, e.g., radioisotope angiography, when other methods were shown to be superior. Two procedures that are now widely and uniquely useful in cardiovascular diagnosis evolved: radionuclide ventriculography, capable of measuring ejection fraction of both ventricles and of demonstrating wall motion abnormalities; and thallium-201 perfusion scanning, which may demonstrate reversible defects, permitting evaluation of myocardium jeopardized by intermittent ischemia.
Cardiac catheterization. Twelve years had elapsed since the demonstration of the feasibility of catheterization of the right side of the heart by Forssman in 1929 when catheterization was applied to the study of circulation by Cournand and Ranges.13 Used initially for investigation of the normal circulation, within a short time cardiac catheterization had been applied to the diagnosis of congenital cardiac lesions.14 The demonstration by Dexter and his associates that a catheter wedged in a distal branch of the pulmonary artery records pressures identical to those from the left atrium15 represented the next major advance. Various methods of entering the left side of the heart were then developed: Vol. 77, No. 5, May 1988 direct percutaneous needle puncture of the left atrium through the back, needle puncture of the left ventricle through the apical region, transseptal left atrial and ventricular catheterization, and retrograde arterial catheterization with the percutaneous technique of Seldinger.16 The latter approach was seminal in the development of selective angiocardiography.
Arrhythmias. Cardiac arrhythmias have fascinated investigators throughout this century. In the 1920s, comprehensive analysis of the mechanisms of arrhythmias had become possible by the development of the electrocardiography. In the 1930s, clinical management of arrhythmias has been applied predominantly to atrial arrhythmias. Ventricular tachycardia was then considered rare.
The availability of the oscilloscopic monitor represented a major advance in the diagnosis of cardiac arrhythmias, largely responsible for the development of coronary care units. The that electric shock can terminate ventricular fibrillation when applied through the intact chest. This innovation was followed by the introduction of closed-chest massage.23 Thus the development of closed-chest resuscitation completely altered the outlook for death due to cardiac arrest. A further step in electric termination of arrhythmia was the introduction by Lown et al.24 of "direct current" shock timed to avoid the ventricular vulnerable period.
SELZER
The development of pacemakers for control of lifethreatening bradycardias represents another major advance in the treatment of arrhythmias. The use of electronic pacemakers became practical when self-contained implantable pacemakers were made available25 in 1960. Initially, thoracotomy was necessary for placement of pacing electrodes on the heart. However, within a short time transvenous introduction of endocardial electrodes made thoracotomy unnecessary. The prototype pacemaker was a fixed-rate ventricular pacer stimulating the heart continuously. Later, inhibition of pacing by a normal rhythm was accomplished with the "standby"pacemaker. Rapid technologic advances led to the dual-chamber, programmable pacemaker used today.
As pacemakers became better and easier to use, other applications were developed. These include termination of certain tachyarrhythmias by pacing overdrive. Induction of ventricular arrhythmias triggered by pacing stimulation has proved to be useful in the evaluation of some arrhythmias and the selection of drugs most effective in suppressing them. 26 Surgical treatment of arrhythmias was introduced first for the prevention of reentry arrhythmias in preexcitation syndromes. It was later applied to control some serious ventricular arrhythmias, although results are not yet uniformly satisfactory.
Cardiac function and cardiac failure. Fifty years ago, impaired performance of the cardiac pump could be recognized only in its latest stages, i.e., with overt cardiac failure. At that time, attempts to evaluate clinically cardiac function were based on simple tests with unfortunately low reliability, e.g., arm-to-tongue circulation time, measurement of peripheral venous pressure, and serial determination of pulmonary vital capacity. The development of cardiac catheterization has permitted direct measurement of circulatory function at rest and with exercise; however, complexity and risk precluded its repeated use under many ordinary clinical conditions. The Even though ballistocardiographic curves did show abnormalities related to a failing heart, their crude and nonspecific nature gave rise to dissipation of initial enthusiasm and the procedure was ultimately abandoned. Another test more directly related to function of the heart has been the measurement of the systolic time intervals by phonocardiography.29 However, it remained for echocardiography and radionuclide ventriculography to provide convenient noninvasive tests capable of demonstrating impaired cardiac contractility.
The introduction of flow-directed cardiac catheters by Swan, Ganz, and associates30 permitted bedside, continuous, hemodynamic monitoring of patients with acute disturbances of cardiac function.
Until the early 1950s, management of patients in cardiac failure was predicated on digitalis, intermittent administration of intravenous diuretics, and mechanical removal of fluid. The management of cardiac failure was significantly altered by the availability of oral diuretics: first, carbonic anhydrase inhibitors, then thiazide diuretics,31 and since 1968, the powerful loop diuretics.32 Easy access to serial electrolyte determinations soon made it possible to monitor diuretic therapy effectively.
A major advance in the medical management of patients in cardiac failure was the introduction of vasodilator therapy by Franciosa et al.33 Agents with positive inotropic effects were found to be useful in some forms of pump failure. Thus parenteral use of catecholamine cogeners yielded beneficial results. Whether newly developed oral agents represent a real advance in the treatment of cardiac failure remains to be determined.
The ultimate treatment of end-stage cardiac failure-cardiac transplantation-was initiated in 1967, based on work by Shumway and his associates.34 However, the initial experience was disappointing: high mortality almost led to abandonment of the procedure until, a decade later, the availability of effective immunosuppressive drugs reestablished transplantation as an acceptable treatment. Today, cardiac transplantation is used widely and often successfully. Congenital heart disease. The complexity and variability of congenital cardiac lesions has fascinated the medical profession for more than a century. Interest was often disproportionate to prevalence, particularly in adult patients. Some of the most spectacular advances in cardiology were first applied to congenital heart disease, e.g., cardiac catheterization and cardiovascular surgery.
Although correct diagnosis of some congenital lesions had been possible on the basis of clinical, radiographic, and electrocardiographic examinations, cardiac catheterization provided a detailed hemody-958 CIRCULATION namic description of each lesion essential for cardiac surgery. Within a very few years after the advent of cardiac catheterization in 1941, atrial septal defects could be documented routinely by catheterization studies.35' 3 Demonstration of other lesions36 soon followed. A decade later, introduction of selective angiocardiography facilitated diagnosis of more complex malformations. The last decade has seen the application of echocardiography to congenital heart disease permitting definitive diagnosis of many lesions without the need for invasive studies.
Congenital heart disease has represented a fertile field for the development and growth of cardiac surgery. Surgical treatment of congenital lesions accounts for many early milestones in cardiovascular surgery. The first surgical operations had dealt with the great vessels: ligation of the patent ductus arteriosus by Gross,37 correction of coarctation of the aorta by Craaford,38 and production of aortopulmonary communications for the relief of cyanotic cardiac lesions by Blalock.39 Early attempts to operate on the heart included pulmonary valvotomy for congenital pulmonary stenosis40 and the repair of atrial septal defect with the "well" method41 or hypothermia. 42 Early models of cardiac pump-oxygenators used in animal experiments were designed more than 50 years ago by Gibbon.43 However, not until two decades later had the first operation been performed in man for the correction of atrial septal defect44 with cardiopulmonary bypass. With progress in technology permitting more prolonged use of aortopulmonary bypass, more complex congenital defects could be attacked. Cardiac surgery soon became applicable for correction of acquired disease of the heart as well.
Valvular heart disease. Two disorders responsible historically for the majority of cases of valvular heart disease have undergone major changes. Syphilis has been largely eliminated by the use of antibiotics. The incidence of rheumatic fever has declined, almost disappearing in many developed countries although still rampant in the less developed areas. Valvular heart disease often presents a mechanical problem well suited to surgical management. Surgical attack on malfunctioning cardiac valves had been suggested as far back as the turn of the century. Successful attempts to dilate surgically stenotic mitral valves were made in the 1920s but initially were abandoned because of the state of general surgery at the time. The successful experience with surgical correction of congenital cardiovascular lesions two decades later prepared cardiac surgeons for valve surgery. Successful mitral valvotomies had been performed simultaneously and but results were poor initially in adults. The first attempt to alleviate the effects of severe aortic regurgitation was made by Hufnagel,48 who inserted a ball valve into the descending aorta to reduce regurgitant volume. This procedure helped occasional patients but obviously did not provide an answer to valve disease. Development of pump-oxygenators permitted operation under direct vision: stenotic lesions could now be relieved.
A major breakthrough in valve surgery came in 1960 with the development of successful artificial valves by Starr and Edwards.49 It should be noted, however, that after nearly three subsequent decades the search for an ideal prosthetic valve continues. Recently, balloon valvuloplasty for mitral and aortic stenosis has been developed and applied successfully.
Coronary artery disease. Half a century ago, the principal stages of coronary artery disease had already been well recognized: stable angina pectoris, unstable angina ("intermediate syndrome"), and acute myocardial infarction. However, it was the classic paper by Blumgart et al.50 in 1940 that clarified the clinicalpathologic relationships, particularly the role of coronary occlusion, in the production of myocardial infarction and the role of collateral circulation, laying the foundation for present concepts of the natural history of this condition.
The electrocardiogram was the principal tool for the diagnosis of myocardial ischemia and infarction. Routine use of multiple precordial leads has greatly improved the sensitivity and specificity of this test. Provocative tests for ischemia based on rapid stair climbing or inhalation of oxygen-poor gas mixture were used but were soon replaced by treadmill stress tests. A major breakthrough was the introduction of selective coronary arteriography1`and the demonstration that it can be performed with considerable safety. Radionuclide tests and echocardiography assumed an important role later in the diagnosis of specific manifestations of coronary disease.
Medical treatment of angina pectoris has consisted of general measures and the use of nitrates. Thirty-five years ago, a new antianginal drug, khellin, had been introduced, which was derived from an Egyptian plant, Ammi visnaga.5' After a short burst of enthusiasm, its use was abandoned. A real advance in antianginal therapy was the introduction of ,3-adrenergic-blocking 959 agents more than 10 years later.52 53 The first effective member of this group, pronethalol, was withdrawn because of potential carcinogenicity. A successor, propranolol, and its analogues represents a mainstay of antianginal treatment. Another more recent major advance was the introduction of calcium channelblocking agents, of particular importance in vasospastic angina pectoris.
Interest in surgical relief of angina dates back more than 50 years. Attempts to relieve the pain by dorsal sympathectomy have not been impressively successful. Beck, in 1935,54 suggested revascularization of the heart via the pericardium by implanting a portion of the pectoral muscle to the pericardium. Shortly thereafter, O'Shaunessy55 devised a similar operation by implanting omentum to the pericardium ("cardio-omentopexy"). Further attempts to revascularize the pericardium have involved various ways to stimulate the visceral pericardium, by scarifying it, by introduction of phenol or talcum powder, all of which were expected to provoke adhesions between the layers of the pericardium. In retrospect, the most bizarre attempt at revascularization of the heart consisted of the ligation of the distal internal mammary artery in the hope that this would stimulate increased flow into its pericardial branches. Each of these operations attracted many enthusiasts, even though no controlled studies proved their merit. Another approach, devised by Vineberg56 in 1946, consisted of implantation of the open end of the internal mammary artery into the myocardium. This procedure attracted little attention until two decades later, when selective contrast visualization of the mammary artery showed in some patients anastomoses between this artery and the coronary branches.3 The operation then became accepted enthusiastically and performed widely despite doubts regarding how often and how effectively collaterization develops.
A major breakthrough in invasive treatment of coronary artery disease came in 1966 with the development of saphenous vein bypass grafts,58 connecting aorta to coronary arterial segments distal to a stenosis. An additive recent advance was Gruentzig's introduction of coronary angioplastyf9
Diagnosis and treatment of acute myocardial infarction have evolved dramatically. A major advance in the diagnosis of myocardial infarction has been the introduction of assays for measurement of enzymes in plasma released from the heart.6') Traditional treatment of myocardial infarction 50 years ago consisted of a 3 to 6 week period of absolute bed rest and supportive management. A series of papers 960 in 194461 62 pointed out the "evils" of bed rest. Early ambulation became the "treatment of choice.* Management of myocardial infarction was improved markedly by introduction of coronary care units. When it became apparent that early ventricular fibrillation in acute myocardial infarction could be reversed easily and that closed-chest resuscitation was possible. continuous monitoring of rhythm was a logical step. In 1962, coronary care units were organized independently in Kansas City, Philadelphia, Toronto, and Sydney. Monitoring of rhythm in coronary care units has improved patient care in the early stages of myocardial infarction greatly, not only in detecting early ventricular fibrillation but also in promptly detecting and addressing other complications. A decade later, bedside hemodynamic monitoring by means of flow-directed catheters further improved the care of patients with pump failure and shock.
Once considered dangerous, nitroglycerin became an important drug in the management of acute myocardial infarction. Other antianginal drugs, 13-adrenergic blockers and calcium-channel blockers, were introduced in the management of acute myocardial infarction. Thrombolytic therapy in the early stages of myocardial infarction is the most recent therapeutic innovation to engender an enthusiastic reception.
Hypertension. The knowledge of a relationship between kidney disease and hypertension dates back to Bright's time. However, Goldblatt's64 experimental production of hypertension by constricting renal arteries in 1934 constituted a milestone in the understanding of this disease. At that time, no drugs capable of reducing arterial pressure were available, and attempts to lower blood pressure by resecting the dorsal sympathetic chain were of questionable value. Goldblatt's studies raised the hope that hypertension could be relieved in special situations, such as a unilaterally diseased kidney that could be resected. However, this procedure was only partly successful. A critical review by Smith in 194865 of all cases of unilateral nephrectomy performed in hypertensive patients showed a success rate of only 19%. Another, more successful example of surgical relief of hypertension of unusual etiology was repair of coarctation of the aorta.
The credit of demonstrating the reversibility of cardiovascular consequences of hypertension should go to Kempner.66 It had been recognized since the 1920s that a low-sodium diet may have a mildly antihypertensive effect in some patients. In 1944, Kempner had designed a rice and fruit diet that provided extreme reduction in sodium content. Within a few years, he was able to CIRCULATION demonstrate not only consistent success in reducing blood pressure but also spectacular reversal of papiledema and other manifestations of hypertensive retinopathy and normalization of the electrocardiographic pattern of left ventricular hypertrophy.
Effective antihypertensive drugs were developed two decades later. Hexamethonium,67 a ganglionic blocking agent effective parenterally, was the first to be introduced, followed by other similar agents effective orally, including pentolinium. Other drugs found to be effective have included hydralazine, rauwolfia alkaloids, and the veratrum alkaloids. Use of these drugs singly or in combination improved the outlook of hypertensive patients. Among the many drugs later introduced, two groups deserve special recognition:
B-adrenergic-blocking agents and angiotensin converting-enzyme inhibitors.
This steady progress in drug therapy of hypertension altered the natural history of this disease. Serious sequelae, such as those typical of its malignant phasehypertensive crises and heart failure -that were once commonplace are seen only rarely now. Today the significance of hypertension lies in its being one of the risk factors accelerating various forms of vascular disease.
Other disorders Infective endocarditis. Until the introduction of penicillin, no cure had been available for endocarditis. The antibiotic era had already been started in Germany more than 50 years ago with the introduction of a sulfonamide agent (Prontosil). The hope that it might be effective in subacute bacterial endocarditis was not fulfilled. Not Cardiomyopathy. Progress in primary diseases of the myocardium involved clarification of its varieties, but unfortunately no significant advance in the prognosis or therapy can be reported, short of cardiac transplantation. In recognizing various forms of cardiomyopathy, a landmark paper was the 1957 case report of Brock69 describing hypertrophic cardiomyopathy in a patient operated on for valvular aortic stenosis. In 1959, Teare70 described hypertrophic cardiomyopathy more broadly.
Pulmonary heart disease. Pulmonary hypertension remains an unsolved problem. Some secondary forms may be reversed by surgical means (correction of valvular disease, elimination of cardiac shunts), but no significant progress in reversing other varieties of pulmonary hypertension have been made.
The current state of the art Changes during the past half century have been, indeed, spectacular. Progress led to improvement of the quality of life of the cardiac patient for virtually all aspects of heart disease. However, only in some diseases have major changes in the natural history and prognosis been accomplished. For example, antibiotics have eliminated or reduced significantly cardiovascular syphilis, infective endocarditis, tuberculous pericarditis and, probably, rheumatic heart disease in some parts of the world. The only disease dramatically changed by other forms of medical therapy is hypertension. Cardiovascular surgery has greatly altered the outlook of congenital and valvular heart diseases.
Cardiology evolved from a subspecialty of general medicine requiring the expertise of interpreting electrocardiograms into a highly complex branch of medicine that now calls for a longer training period than any other nonsurgical specialty or subspecialty. Furthermore, cardiology now includes some special skills that require even additional training (e.g., invasive electrophysiology, interventional cardiology).
The rapid introduction of highly touted technologic advances and a constant flow of newly released drugs make it difficult to evaluate their appropriate places in clinical cardiology. To validate such new advances, randomized trials are being conducted here and abroad. Even though many such trials have provided valuable data and therapeutic guidance, several papers have appeared pointing out the difficulty of designing trials with genuine relevance to clinical practice, advocating caution in interpretion of their results. [71] [72] [73] [74] [75] Modern cardiology faces many problems. Technologic advances are associated with great expense, which is compounded by rapid obsolescence of equipment already purchased. As a result, cardiology is a major contributor to the rapid rise of the cost of health care.
Several forces affect delivery of cardiac care: Medical advances are given much publicity. The general public's interest and knowledge of medical matters is high and often fed by premature and exaggerated reports of advances by the media. As a result, patients expect and demand "the latest" and physicians are under pressure to "deliver."
As "gatekeepers," cardiologists are subject to the high-pressure salesmanship of the pharmaceutical industry and manufacturers of medical instruments and devices. The change from a minimum of effective cardiac drugs to the present "embarras de richesses" encourages excessive use of drugs and procedures with 961 Vol. 77, No. 5, May 1988 emphasis on those most recently released, which are often (and sometimes inappropriately) assumed to be the best. It is sometimes overlooked that long-term use of cardiovascular drugs may have a negative effect on the quality of life.
Pressure from the legal profession has resulted in a "malpractice crisis." The fear of litigation encourages excessive use of diagnostic tests and therapeutic interventions on the assumption that it may be safer than to risk blame for not taking a specific step, even if it is not medically indicated.
Regulatory restrictions of cardiovascular facilities are lax or absent in many states. As a result, small community hospitals often pose as tertiary cardiac centers, performing the most complex procedures. There some evidence that the risk of procedures may be too high in units with a small case load. Furthermore, the excess of facilities encourages overuse of some procedures. We perform two to four times as many coronary bypass operations and pacemaker placements per capita as almost all other western countries.
Today's cardiologist tends to rely heavily on technology at the expense of traditional diagnosis skills. An instant diagnosis of valvular or congenital cardiac lesions can be obtained from the echocardiogram. It may be easier to acquire one than to pay attention to the traditional history and physical examination.
Progress requires intensive postgraduate education of the practicing physician. More and more educational functions are being assumed by pharmaceutical firms and equipment manufacturers. They offer symposia, often combined with lavish entertainment, which may sometimes lead to bias in favor of their particular products.
Cardiology has come a long way in the past half century. Progress is exponential. Nevertheless, the cardiologist must remain a clinician rather than a "cardiac technologist" if the patient is to be served optimally. 
